Search

Your search keyword '"Kaneda, Kazuhisa"' showing total 239 results
Start Over Author "Kaneda, Kazuhisa"
239 results on '"Kaneda, Kazuhisa"'

1. Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2

Author

Takabayashi, Kensuke, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Ono, Koh, and Kimura, Takeshi

Published
2024
Full Text
View/download PDF

2. Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2

Author

Mabuchi, Hiroshi, Nishikawa, Ryusuke, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Ono, Koh, Nakagawa, Yoshihisa, and Kimura, Takeshi

Published
2024
Full Text
View/download PDF

3. Initial anticoagulation therapy with single direct oral anticoagulant in patients with intermediate-high risk acute pulmonary embolism: From the COMMAND VTE Registry-2

Author

Shigeno, Ryo, Kim, Kitae, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Furukawa, Yutaka, and Kimura, Takeshi

Published
2025
Full Text
View/download PDF

5. Abstract 4137138: Incidence and Risk factors of Early Mortality in Symptomatic Acute PE: Recent Insights from the COMMAND VTE Registry-2

Author

Kobayashi, Soichiro, Ogihara, Yoshito, Yamashita, Yugo, Chatani, Ryuki, kaneda, kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Nishikawa, Ryusuke, Sato, Toru, and Dohi, Kaoru

Published
2024
Full Text
View/download PDF

6. Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the Contemporary Management and Outcomes in Patients With Venous Thromboembolism Registry-2

Author

Sato, Toru, Ogihara, Yoshito, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Kimura, Takeshi, and Dohi, Kaoru

Published
2024
Full Text
View/download PDF

7. External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2

Author

Kaneda, Kazuhisa, Nishikawa, Ryusuke, Yamashita, Yugo, Chatani, Ryuki, Mushiake, Kazunori, Kadota, Kazushige, Nishimoto, Yuji, Sato, Yukihito, Ikeda, Nobutaka, Amemiya, Katsushi, Nakamura, Masato, Kobayashi, Yohei, Kimura, Ren, Inada, Tsukasa, Ikeda, Satoshi, Ueno, Yuki, Maemura, Koji, Kim, Kitae, Shigeno, Ryo, Furukawa, Yutaka, inoko, Moriaki, Ito, Shinya, Takase, Toru, Nakazawa, Gaku, Tsuji, Shuhei, Toyofuku, Mamoru, Oi, Maki, Kaitani, Kazuaki, Takada, Takuma, Jujo, Kentaro, Hagiwara, Nobuhisa, Otsui, Kazunori, Mori, Kenta, Sakamoto, Jiro, Tamura, Toshihiro, Morimoto, Takeshi, Inoko, Moriaki, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Watanabe, Tetsuya, Yamada, Takahisa, Fukunami, Masatake, and Kimura, Takeshi

Published
2024
Full Text
View/download PDF

8. Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry

Author

Kanenawa, Kenji, Yamaji, Kyohei, Morimoto, Takeshi, Yamamoto, Ko, Domei, Takenori, Hyodo, Makoto, Shiomi, Hiroki, Furukawa, Yutaka, Nakagawa, Yoshihisa, Kadota, Kazushige, Watanabe, Hirotoshi, Yoshikawa, Yusuke, Tada, Tomohisa, Tazaki, Junichi, Ehara, Natsuhiko, Taniguchi, Ryoji, Tamura, Toshihiro, Iwakura, Atsushi, Tada, Takeshi, Suwa, Satoru, Toyofuku, Mamoru, Inada, Tsukasa, Kaneda, Kazuhisa, Ogawa, Tatsuya, Takeda, Teruki, Sakai, Hiroshi, Yamamoto, Takashi, Tambara, Keiichi, Esaki, Jiro, Eizawa, Hiroshi, Yamada, Miho, Shinoda, Eiji, Nishizawa, Junichiro, Mabuchi, Hiroshi, Tamura, Nobushige, Shirotani, Manabu, Nakayama, Shogo, Uegaito, Takashi, Matsuda, Mitsuo, Takahashi, Mamoru, Inoko, Moriaki, Kanemitsu, Naoki, Tamura, Takashi, Ishii, Katsuhisa, Nawada, Ryuzo, Onodera, Tomoya, Ohno, Nobuhisa, Koyama, Tadaaki, Tsuneyoshi, Hiroshi, Sakamoto, Hiroki, Aoyama, Takeshi, Miki, Shinji, Tanaka, Masaru, Sato, Yukihito, Yamazaki, Fumio, Hanyu, Michiya, Soga, Yoshiharu, Komiya, Tatsuhiko, Minatoya, Kenji, Ando, Kenji, and Kimura, Takeshi

Published
2024
Full Text
View/download PDF

9. Effects of peripheral artery disease on long-term outcomes after percutaneous coronary intervention versus coronary artery bypass grafting in patients with severe coronary artery disease

Author

Nishikawa, Ryusuke, Shiomi, Hiroki, Morimoto, Takeshi, Yamamoto, Ko, Sakamoto, Hiroki, Tada, Tomohisa, Kaneda, Kazuhisa, Nagao, Kazuya, Nakatsuma, Kenji, Tazaki, Junichi, Suwa, Satoru, Inoko, Moriaki, Yamazaki, Kazuhiro, Tsuneyoshi, Hiroshi, Komiya, Tatsuhiko, Ando, Kenji, Minatoya, Kenji, Furukawa, Yutaka, Nakagawa, Yoshihisa, and Kimura, Takeshi

Published
2024
Full Text
View/download PDF

11. Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysis

Author

Ikeda, Shinya, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Ono, Koh, and Kimura, Takeshi

Published
2024
Full Text
View/download PDF

13. Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2

Author

Ogihara, Yoshito, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Sato, Toru, Nishikawa, Ryusuke, Kimura, Takeshi, and Dohi, Kaoru

Published
2024
Full Text
View/download PDF

14. Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2

Author

Chatani, Ryuki, Yamashita, Yugo, Morimoto, Takeshi, Mushiake, Kazunori, Kadota, Kazushige, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, and Kimura, Takeshi

Published
2024
Full Text
View/download PDF

16. The Impact of Mitral Regurgitation on Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Author

Obayashi, Yuki, Shiomi, Hiroki, Morimoto, Takeshi, Miyake, Makoto, Inoko, Moriaki, Nishikawa, Ryusuke, Kaneda, Kazuhisa, Yamamoto, Ko, Takeji, Yasuaki, Tada, Tomohisa, Nagao, Kazuya, Uegaito, Takashi, Ehara, Natsuhiko, Sakai, Hiroshi, Suwa, Satoru, Tamura, Toshihiro, Sakamoto, Hiroki, Inada, Tsukasa, Matsuda, Mitsuo, Sato, Yukihito, Furukawa, Yutaka, Ando, Kenji, Kadota, Kazushige, Nakagawa, Yoshihisa, and Kimura, Takeshi

Published
2023
Full Text
View/download PDF

17. Post-contrast Acute Kidney Injury After Emergent and Elective Percutaneous Coronary Intervention (from the CREDO-Kyoto PCI/CABG Registry Cohort 3)

Author

Kaneda, Kazuhisa, Shiomi, Hiroki, Abe, Mitsuru, Morimoto, Takeshi, Yamamoto, Ko, Obayashi, Yuki, Nishikawa, Ryusuke, Tamura, Akinori, Kadota, Kazushige, Domei, Takenori, Nakatsuma, Kenji, Yokomatsu, Takafumi, Imai, Masao, Taniguchi, Tomohiko, Nawada, Ryuzo, Toyofuku, Mamoru, Tamura, Toshihiro, Inada, Tsukasa, Matsuda, Mitsuo, Sato, Yukihito, Furukawa, Yutaka, Ando, Kenji, Nakagawa, Yoshihisa, and Kimura, Takeshi

Published
2023
Full Text
View/download PDF

18. Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial

Author

Yaku, Hidenori, Kato, Takao, Morimoto, Takeshi, Kaneda, Kazuhisa, Nishikawa, Ryusuke, Kitai, Takeshi, Inuzuka, Yasutaka, Tamaki, Yodo, Yamazaki, Taketoshi, Kitamura, Jun, Ezaki, Hirotaka, Nagao, Kazuya, Yamamoto, Hiromi, Isotani, Akihiro, Takeshi, Arita, Izumi, Chisato, Sato, Yukihito, Nakagawa, Yoshihisa, Matoba, Satoaki, Sakata, Yasushi, Kuwahara, Koichiro, and Kimura, Takeshi

Published
2023
Full Text
View/download PDF

25. Stroke Risk Stratification With the CHADS2 Score in Patients Without Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention

Author

Obayashi, Yuki, Shiomi, Hiroki, Morimoto, Takeshi, Tamaki, Yodo, Inoko, Moriaki, Nishikawa, Ryusuke, Kaneda, Kazuhisa, Yamamoto, Ko, Takeji, Yasuaki, Komasa, Akihiro, Yamaji, Kyohei, Shizuta, Satoshi, Tada, Tomohisa, Nagao, Kazuya, Suwa, Satoru, Tamura, Toshihiro, Sakamoto, Hiroki, Inada, Tsukasa, Matsuda, Mitsuo, Sato, Yukihito, Furukawa, Yutaka, Ando, Kenji, Kadota, Kazushige, Nakagawa, Yoshihisa, and Kimura, Takeshi

Published
2022
Full Text
View/download PDF

27. Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization: CREDO-Kyoto PCI/CABG Registry

Author

Kimura, Takeshi, Shiomi, Hiroki, Matsuda, Mitsuo, Takeuchi, Yuzo, Mitsuoka, Hirokazu, Uegaito, Takashi, Nakagawa, Yoshihisa, Tamura, Toshihiro, Konishi, Takashi, Ootani, Seiji, Fujiwara, Hisayoshi, Takatsu, Yoshiki, Sato, Yukihito, Taniguchi, Ryoji, Kataoka, Kazuaki, Inoko, Moriaki, Nohara, Ryuji, Nakano, Kimisato, Miyamoto, Syoichi, Kunihiko, Nagai, Murakami, Tomoyuki, Takeda, Teruki, Ishida, Katsuya, Nobuyoshi, Masakiyo, Yamaji, Kyohei, Yasumoto, Hitoshi, Iwabuchi, Masashi, Ando, Kenji, Domei, Takenori, Kato, Masayuki, Tatami, Ryozo, Shirotani, Manabu, Hattori, Ryuichi, Kita, Toru, Furukawa, Yutaka, Ehara, Natsuhiko, Kihara, Yasuki, Eizawa, Hiroshi, Kato, Hiroshi, Ishii, Katsuhisa, Aoyama, Takeshi, Sakurai, Takahiro, Kawanami, Masaki, Suyama, Tamaki, Tada, Eiji, Tanaka, Masaru, Inada, Tsukasa, Uzui, Hiroyasu, Nakano, Akira, Lee, Jong-Dae, Onodera, Tomoya, Takizawa, Akinori, Ryuzo, Nawada, Shinoda, Eiji, Takahashi, Masaaki, Yamada, Miho, Horie, Minoru, Yamamoto, Takashi, Takashima, Hiroyuki, Sakai, Hiroshi, Tamura, Takashi, Toyofuku, Mamoru, Kotoura, Hajime, Miura, Akira, Takahashi, Mamoru, Matoba, Yoshiki, Takumi, Takuro, Tei, Chuwa, Hamasaki, Shuichi, Doi, Osamu, Kambara, Hirofumi, Kaburagi, Satoshi, Sakamoto, Hiroki, Tada, Tomohisa, Mitsudo, Kazuaki, Kadota, Kazushige, Tada, Takeshi, Miki, Shinji, Mizoguchi, Tetsu, Akira, Yoshida, Kaneda, Kazuhisa, Ogawa, Hisao, Sugamura, Koichi, Sugiyama, Seigo, Doyama, Kiyoshi, Araki, Makoto, Suwa, Satoru, Sakata, Ryuzo, Ikeda, Tadashi, Marui, Akira, Minatoya, Kenji, Yamazaki, Kazuhiro, Onoe, Masahiko, Ogawa, Tatsuya, Yamanaka, Kazuo, Iwakura, Atsushi, Ohno, Nobuhisa, Fujiwara, Keiichi, Hanyu, Michiya, Soga, Kinji, Matsushita, Tsutomu, Nishiwaki, Noboru, Yoshida, Yuichi, Tamura, Nobushige, Okada, Yukikatsu, Nasu, Michihiro, Koyama, Tadaaki, Nakayama, Shogo, Tanaka, Kuniyoshi, Koshiji, Takaaki, Morioka, Koichi, Shimamoto, Mitsuomi, Yamazaki, Fumio, Terai, Yasuhiko, Nishizawa, Junichiro, Aota, Masaki, Kanemitsu, Naoki, Hara, Hiroyuki, Tabata, Takafumi, Imoto, Yutaka, Yamamoto, Hiroyuki, Matsuda, Katsuhiko, Nara, Masafumi, Tsuneyoshi, Hiroshi, Komiya, Tatsuhiko, Nakajima, Hiroyuki, Esaki, Jiro, Kawasuji, Michio, Moriyama, Syuji, Tambara, Keiichi, Arimura, Sakiko, Fujino, Yumika, Hanazawa, Miya, Hibi, Chikako, Kato, Risa, Kinoshita, Yui, Kitagawa, Kumiko, Kitamura, Masayo, Kuwahara, Takahiro, Sachiko, Maeda, Miki, Izumi, Minematsu, Saeko, Nishida, Satoko, Okamoto, Naoko, Saeki, Asuka, Sasae, Hitomi, Sato, Yuki, Takahashi, Asuka, Takinami, Emi, Tezuka, Saori, Tsuda, Marina, Tsumori, Miyuki, Uchida, Yuriko, Yamamoto, Yuko, Yamauchi, Misato, Yamazaki, Itsuki, Yoshimoto, Mai, Abe, Mitsuru, Fuki, Masayuki, Hayano, Mamoru, Kato, Eri, Kato, Yoshihiro, Matsumura-Nakano, Yukiko, Nakajima, Tetsu, Nakatsuma, Kenji, Natsuaki, Masahiro, Takeji, Yasuaki, Tazaki, Junichi, Tokushige, Akihiro, Watanabe, Hiroki, Yaku, Hidenori, Yamamoto, Erika, Yamamoto, Ko, Yamashita, Yugo, Yoshikawa, Yusuke, Morimoto, Takeshi, Kato, Eri T., Imada, Kazuaki, Nishikawa, Ryusuke, Mabuchi, Hiroshi, and Soga, Yoshiharu

Published
2022
Full Text
View/download PDF

28. Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation

Author

Yamamoto, Ko, Natsuaki, Masahiro, Morimoto, Takeshi, Shiomi, Hiroki, Yoshikawa, Yusuke, Tazaki, Junichi, Tada, Takeshi, Watanabe, Hirotoshi, Kato, Eri, Toyofuku, Mamoru, Inada, Tsukasa, Kaneda, Kazuhisa, Takeda, Teruki, Sakai, Hiroshi, Yamamoto, Takashi, Eizawa, Hiroshi, Yamada, Miho, Shinoda, Eiji, Mabuchi, Hiroshi, Shirotani, Manabu, Matsuda, Mitsuo, Takahashi, Mamoru, Ishii, Katsuhisa, Onodera, Tomoya, Sakamoto, Hiroki, Aoyama, Takeshi, Miki, Shinji, Ando, Kenji, and Kimura, Takeshi

Published
2022
Full Text
View/download PDF

29. External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2

Author

Nishimoto, Yuji, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Sato, Yukihito, Watanabe, Tetsuya, Yamada, Takahisa, Fukunami, Masatake, Kimura, Takeshi, Kaneda, Kazuhisa, Nishikawa, Ryusuke, Yamashita, Yugo, Chatani, Ryuki, Mushiake, Kazunori, Kadota, Kazushige, Nishimoto, Yuji, Sato, Yukihito, Ikeda, Nobutaka, Amemiya, Katsushi, Nakamura, Masato, Kobayashi, Yohei, Kimura, Ren, Inada, Tsukasa, Ikeda, Satoshi, Ueno, Yuki, Maemura, Koji, Kim, Kitae, Shigeno, Ryo, Furukawa, Yutaka, inoko, Moriaki, Ito, Shinya, Takase, Toru, Nakazawa, Gaku, Tsuji, Shuhei, Toyofuku, Mamoru, Oi, Maki, Kaitani, Kazuaki, Takada, Takuma, Jujo, Kentaro, Hagiwara, Nobuhisa, Otsui, Kazunori, Mori, Kenta, Sakamoto, Jiro, and Tamura, Toshihiro

Abstract

There is no established risk score for anticoagulant-related bleeding during the acute phase in patients with pulmonary embolism (PE). The PE-Syncope, Anemia, and Renal Dysfunction (PE-SARD) bleeding score was developed to predict early major bleeding but has not yet been fully externally validated.

Published
2024
Full Text
View/download PDF

31. Coronary Revascularization in the Past Two Decades in Japan (From the CREDO-Kyoto PCI/CABG Registries Cohort-1, -2, and -3)

Author

Shiomi, Hiroki, Morimoto, Takeshi, Furukawa, Yutaka, Nakagawa, Yoshihisa, Kadota, Kazushige, Yoshikawa, Yusuke, Yamaji, Kyohei, Tada, Tomohisa, Tazaki, Junichi, Ehara, Natsuhiko, Taniguchi, Ryoji, Tamura, Toshihiro, Iwakura, Atsushi, Tada, Takeshi, Watanabe, Hirotoshi, Suwa, Satoru, Toyofuku, Mamoru, Inada, Tsukasa, Kaneda, Kazuhisa, Ogawa, Tatsuya, Takeda, Teruki, Sakai, Hiroshi, Yamamoto, Takashi, Tambara, Keiichi, Esaki, Jiro, Eizawa, Hiroshi, Yamada, Miho, Shinoda, Eiji, Nishizawa, Junichiro, Mabuchi, Hiroshi, Tamura, Nobushige, Shirotani, Manabu, Nakayama, Shogo, Uegaito, Takashi, Matsuda, Mitsuo, Takahashi, Mamoru, Inoko, Moriaki, Kanemitsu, Naoki, Tamura, Takashi, Ishii, Kazuhisa, Nawada, Ryuzo, Onodera, Tomoya, Ohno, Nobuhisa, Koyama, Tadaaki, Tsuneyoshi, Hiroshi, Sakamoto, Hiroki, Aoyama, Takeshi, Miki, Shinji, Tanaka, Masaru, Sato, Yukihito, Yamazaki, Fumio, Hanyu, Michiya, Soga, Yoshiharu, Komiya, Tatsuhiko, Ando, Kenji, Minatoya, Kenji, and Kimura, Takeshi

Published
2021
Full Text
View/download PDF

32. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3)

Author

Yamamoto, Ko, Shiomi, Hiroki, Morimoto, Takeshi, Kadota, Kazushige, Tada, Tomohisa, Takeji, Yasuaki, Matsumura-Nakano, Yukiko, Yoshikawa, Yusuke, Imada, Kazuaki, Domei, Takenori, Kaneda, Kazuhisa, Taniguchi, Ryoji, Ehara, Natsuhiko, Nawada, Ryuzo, Natsuaki, Masahiro, Yamaji, Kyohei, Toyofuku, Mamoru, Kanemitsu, Naoki, Shinoda, Eiji, Suwa, Satoru, Iwakura, Atsushi, Tamura, Toshihiro, Soga, Yoshiharu, Inada, Tsukasa, Matsuda, Mitsuo, Koyama, Tadaaki, Aoyama, Takeshi, Sato, Yukihito, Furukawa, Yutaka, Ando, Kenji, Yamazaki, Fumio, Komiya, Tatsuhiko, Minatoya, Kenji, Nakagawa, Yoshihisa, and Kimura, Takeshi

Published
2021
Full Text
View/download PDF

33. Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry

Author

Kaneda, Kazuhisa, Yamashita, Yugo, Morimoto, Takeshi, Amano, Hideo, Takase, Toru, Hiramori, Seiich, Kim, Kitae, Oi, Maki, Akao, Masaharu, Kobayashi, Yohei, Toyofuku, Mamoru, Morita, Yusuke, Tada, Tomohisa, Chen, Po-Min, Murata, Koichiro, Tsuyuki, Yoshiaki, Nakagawa, Yoshihisa, Nishimoto, Yuji, Saga, Syunsuke, Sakamoto, Jiro, Kinoshita, Minako, Togi, Kiyonori, Ishii, Katsuhisa, Mabuchi, Hiroshi, Takabayashi, Kensuke, Hojo, Shun, Kawaji, Tetsuma, Kushiyama, Akihiro, Yaku, Hidenori, Nakatsuma, Kenji, Kato, Masashi, Yokomatsu, Takafumi, Miki, Shinji, and Kimura, Takeshi

Published
2021
Full Text
View/download PDF

34. Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2.

Author

Sueta, Daisuke, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Nishimoto, Yuji, Kaneda, Kazuhisa, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, and Usami, Shunsuke

Published
2024
Full Text
View/download PDF

36. Efficacy and safety of Saireito (TJ-114) in patients with atrial fibrillation undergoing catheter ablation procedures: A randomized pilot study.

Author

Kawaji, Tetsuma, Shizuta, Satoshi, Yaku, Hidenori, Kaneda, Kazuhisa, Yoneda, Fumiya, Nishiwaki, Shushi, Tanaka, Munekazu, Aizawa, Takanori, Hojo, Shun, Nakatsuma, Kenji, Kato, Masashi, Yokomatsu, Takafumi, Miki, Shinji, Ono, Koh, and Kimura, Takeshi

Abstract

Background: Early arrhythmia recurrences commonly occur after atrial fibrillation (AF) ablation because of irritability and inflammation of left atrium. We hypothesized that short-term use of Saireito would be effective in reducing frequent atrial tachyarrhythmias in the early-phase post-ablation. Methods: One hundred patients undergoing catheter ablation for symptomatic AF were randomly assigned to either a 30-day use of Saireito or control group. The primary endpoint was total number of episodes of frequent atrial tachyarrhythmias including definite recurrent AF and frequent premature atrial contractions during the 30-day treatment period post-ablation. Results: Three (6.0%) out of 50 patients treated with Saireito discontinued the drug because of adverse symptoms. The Saireito group was associated with a numerically lower number of episodes of frequent atrial tachyarrhythmias than the control group (3.1 versus 5.2 times, P = 0.17). The mean daily episodes of frequent atrial tachyarrhythmias were significantly fewer in the Saireito group during Day-6 to Day-10 (0.12/day versus 0.27/day, P = 0.03), and during Day-11 to Day-15 (0.08/day versus 0.24/day, P = 0.001). The prevalence of adverse symptoms during the 30-day treatment period was significantly higher in the Saireito group (18.0% versus 2.0%, P = 0.005). Conclusions: Thirty-day use of Saireito following AF ablation was associated with a tendency toward reduced number of episodes of frequent atrial tachyarrhythmias during the treatment period, with more pronounced effect in the first two weeks. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

37. Finite-size scaling for the Ising model on the Moebius strip and the Klein bottle

Author

Kaneda, Kazuhisa and Okabe, Yutaka

Subjects
Condensed Matter - Statistical Mechanics
Abstract

We study the finite-size scaling properties of the Ising model on the Moebius strip and the Klein bottle. The results are compared with those of the Ising model under different boundary conditions, that is, the free, cylindrical, and toroidal boundary conditions. The difference in the magnetization distribution function $p(m)$ for various boundary conditions is discussed in terms of the number of the percolating clusters and the cluster size. We also find interesting aspect-ratio dependence of the value of the Binder parameter at $T=T_c$ for various boundary conditions. We discuss the relation to the finite-size correction calculations for the dimer statistics., Comment: 4 pages including 5 eps figures, RevTex, to appear in Phys. Rev. Lett

Published
2001
Full Text
View/download PDF

38. Cluster Analysis of the Ising Model and Universal Finite-Size Scaling

Author

Okabe, Yutaka, Kaneda, Kazuhisa, Tomita, Yusuke, Kikuchi, Macoto, and Hu, Chin-Kun

Subjects
Condensed Matter - Statistical Mechanics
Abstract

The recent progress in the study of finite-size scaling (FSS) properties of the Ising model is briefly reviewed. We calculate the universal FSS functions for the Binder parameter $g$ and the magnetization distribution function $p(m)$ for the Ising model on $L_1 \times L_2$ two-dimensional lattices with tilted boundary conditions. We show that the FSS functions are universal for fixed sets of the aspect ratio $L_1/L_2$ and the tilt parameter. We also study the percolating properties of the Ising model, giving attention to the effects of the aspect ratio of finite systems. We elucidate the origin of the complex structure of $p(m)$ for the system with large aspect ratio by the multiple-percolating-cluster argument., Comment: 11 pages including 6 eps figures, elsart.sty, to appear in Physica A

Published
2000
Full Text
View/download PDF

39. Shape Effects of Finite-Size Scaling Functions for Anisotropic Three-Dimensional Ising Models

Author

Kaneda, Kazuhisa, Okabe, Yutaka, and Kikuchi, Macoto

Subjects
Condensed Matter - Statistical Mechanics
Abstract

The finite-size scaling functions for anisotropic three-dimensional Ising models of size $L_1 \times L_1 \times aL_1$ ($a$: anisotropy parameter) are studied by Monte Carlo simulations. We study the $a$ dependence of finite-size scaling functions of the Binder parameter $g$ and the magnetization distribution function $p(m)$. We have shown that the finite-size scaling functions for $p(m)$ at the critical temperature change from a two-peak structure to a single-peak one by increasing or decreasing $a$ from 1. We also study the finite-size scaling near the critical temperature of the layered square-lattice Ising model, when the systems have a large two-dimensional anisotropy. We have found the three-dimensional and two-dimensional finite-size scaling behavior depending on the parameter which is fixed; a unified view of 3D and 2D finite-size scaling behavior has been obtained for the anisotropic 3D Ising models., Comment: 6 pages including 11 eps figures, RevTeX, to appear in J. Phys. A

Published
1999
Full Text
View/download PDF

41. Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization

Author

Yamaji, Kyohei, primary, Shiomi, Hiroki, additional, Morimoto, Takeshi, additional, Matsumura-Nakano, Yukiko, additional, Ehara, Natsuhiko, additional, Sakamoto, Hiroki, additional, Takeji, Yasuaki, additional, Yoshikawa, Yusuke, additional, Yamamoto, Ko, additional, Kato, Eri T., additional, Imada, Kazuaki, additional, Tada, Takeshi, additional, Taniguchi, Ryoji, additional, Nishikawa, Ryusuke, additional, Tada, Tomohisa, additional, Uegaito, Takashi, additional, Ogawa, Tatsuya, additional, Yamada, Miho, additional, Takeda, Teruki, additional, Eizawa, Hiroshi, additional, Tamura, Nobushige, additional, Tambara, Keiichi, additional, Suwa, Satoru, additional, Shirotani, Manabu, additional, Tamura, Toshihiro, additional, Inoko, Moriaki, additional, Nishizawa, Junichiro, additional, Natsuaki, Masahiro, additional, Sakai, Hiroshi, additional, Yamamoto, Takashi, additional, Kanemitsu, Naoki, additional, Ohno, Nobuhisa, additional, Ishii, Katsuhisa, additional, Marui, Akira, additional, Tsuneyoshi, Hiroshi, additional, Terai, Yasuhiko, additional, Nakayama, Shogo, additional, Yamazaki, Kazuhiro, additional, Takahashi, Mamoru, additional, Tamura, Takashi, additional, Esaki, Jiro, additional, Miki, Shinji, additional, Onodera, Tomoya, additional, Mabuchi, Hiroshi, additional, Furukawa, Yutaka, additional, Tanaka, Masaru, additional, Komiya, Tatsuhiko, additional, Soga, Yoshiharu, additional, Hanyu, Michiya, additional, Domei, Takenori, additional, Ando, Kenji, additional, Kadota, Kazushige, additional, Minatoya, Kenji, additional, Nakagawa, Yoshihisa, additional, Kimura, Takeshi, additional, Matsuda, Mitsuo, additional, Takeuchi, Yuzo, additional, Mitsuoka, Hirokazu, additional, Konishi, Takashi, additional, Ootani, Seiji, additional, Fujiwara, Hisayoshi, additional, Takatsu, Yoshiki, additional, Sato, Yukihito, additional, Kataoka, Kazuaki, additional, Nohara, Ryuji, additional, Nakano, Kimisato, additional, Miyamoto, Syoichi, additional, Kunihiko, Nagai, additional, Murakami, Tomoyuki, additional, Ishida, Katsuya, additional, Nobuyoshi, Masakiyo, additional, Yamaji, Kyohei, additional, Yasumoto, Hitoshi, additional, Iwabuchi, Masashi, additional, Kato, Masayuki, additional, Tatami, Ryozo, additional, Hattori, Ryuichi, additional, Kita, Toru, additional, Kihara, Yasuki, additional, Kato, Hiroshi, additional, Aoyama, Takeshi, additional, Sakurai, Takahiro, additional, Kawanami, Masaki, additional, Suyama, Tamaki, additional, Tada, Eiji, additional, Inada, Tsukasa, additional, Uzui, Hiroyasu, additional, Nakano, Akira, additional, Lee, Jong-Dae, additional, Takizawa, Akinori, additional, Ryuzo, Nawada, additional, Shinoda, Eiji, additional, Takahashi, Masaaki, additional, Horie, Minoru, additional, Takashima, Hiroyuki, additional, Toyofuku, Mamoru, additional, Kotoura, Hajime, additional, Miura, Akira, additional, Matoba, Yoshiki, additional, Takumi, Takuro, additional, Tei, Chuwa, additional, Hamasaki, Shuichi, additional, Doi, Osamu, additional, Kambara, Hirofumi, additional, Kaburagi, Satoshi, additional, Mitsudo, Kazuaki, additional, Mizoguchi, Tetsu, additional, Akira, Yoshida, additional, Kaneda, Kazuhisa, additional, Ogawa, Hisao, additional, Sugamura, Koichi, additional, Sugiyama, Seigo, additional, Doyama, Kiyoshi, additional, Araki, Makoto, additional, Sakata, Ryuzo, additional, Ikeda, Tadashi, additional, Onoe, Masahiko, additional, Yamanaka, Kazuo, additional, Iwakura, Atsushi, additional, Fujiwara, Keiichi, additional, Soga, Kinji, additional, Matsushita, Tsutomu, additional, Nishiwaki, Noboru, additional, Yoshida, Yuichi, additional, Okada, Yukikatsu, additional, Nasu, Michihiro, additional, Koyama, Tadaaki, additional, Tanaka, Kuniyoshi, additional, Koshiji, Takaaki, additional, Morioka, Koichi, additional, Shimamoto, Mitsuomi, additional, Yamazaki, Fumio, additional, Aota, Masaki, additional, Hara, Hiroyuki, additional, Tabata, Takafumi, additional, Imoto, Yutaka, additional, Yamamoto, Hiroyuki, additional, Matsuda, Katsuhiko, additional, Nara, Masafumi, additional, Nakajima, Hiroyuki, additional, Kawasuji, Michio, additional, Moriyama, Syuji, additional, Arimura, Sakiko, additional, Fujino, Yumika, additional, Hanazawa, Miya, additional, Hibi, Chikako, additional, Kato, Risa, additional, Kinoshita, Yui, additional, Kitagawa, Kumiko, additional, Kitamura, Masayo, additional, Kuwahara, Takahiro, additional, Sachiko, Maeda, additional, Miki, Izumi, additional, Minematsu, Saeko, additional, Nishida, Satoko, additional, Okamoto, Naoko, additional, Saeki, Asuka, additional, Sasae, Hitomi, additional, Sato, Yuki, additional, Takahashi, Asuka, additional, Takinami, Emi, additional, Tezuka, Saori, additional, Tsuda, Marina, additional, Tsumori, Miyuki, additional, Uchida, Yuriko, additional, Yamamoto, Yuko, additional, Yamauchi, Misato, additional, Yamazaki, Itsuki, additional, Yoshimoto, Mai, additional, Abe, Mitsuru, additional, Fuki, Masayuki, additional, Hayano, Mamoru, additional, Kato, Eri, additional, Kato, Yoshihiro, additional, Nakajima, Tetsu, additional, Nakatsuma, Kenji, additional, Tazaki, Junichi, additional, Tokushige, Akihiro, additional, Watanabe, Hiroki, additional, Yaku, Hidenori, additional, Yamamoto, Erika, additional, and Yamashita, Yugo, additional

Published
2022
Full Text
View/download PDF

43. Different Kinetics of Activated Clotting Time among Uninterrupted Oral Anticoagulants during Catheter Ablation Procedure

Author

Kawaji, Tetsuma, primary, Morimoto, Takeshi, additional, Aizawa, Takanori, additional, Hojo, Shun, additional, Kushiyama, Akihiro, additional, Yaku, Hidenori, additional, Nakatsuma, Kenji, additional, Kaneda, Kazuhisa, additional, Kato, Masashi, additional, Yokomatsu, Takafumi, additional, Miki, Shinji, additional, and Kimura, Takeshi, additional

Published
2021
Full Text
View/download PDF

46. The impact of current strategy using intracardiac echocardiography, lesion index, and minimum substrate ablation on clinical outcomes after catheter ablation procedure for atrial fibrillation

Author

Kawaji, Tetsuma, primary, Aizawa, Takanori, additional, Hojo, Shun, additional, Kushiyama, Akihiro, additional, Yaku, Hidenori, additional, Nakatsuma, Kenji, additional, Kaneda, Kazuhisa, additional, Kato, Masashi, additional, Yokomatsu, Takafumi, additional, and Miki, Shinji, additional

Published
2021
Full Text
View/download PDF

47. Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction

Author

50728037, 50860582, Obayashi, Yuki, Shiomi, Hiroki, Morimoto, Takeshi, Tamaki, Yodo, Inoko, Moriaki, Yamamoto, Ko, Takeji, Yasuaki, Tada, Tomohisa, Nagao, Kazuya, Yamaji, Kyohei, Kaneda, Kazuhisa, Suwa, Satoru, Tamura, Toshihiro, Sakamoto, Hiroki, Inada, Tsukasa, Matsuda, Mitsuo, Sato, Yukihito, Furukawa, Yutaka, Ando, Kenji, Kadota, Kazushige, Nakagawa, Yoshihisa, Kimura, Takeshi, 50728037, 50860582, Obayashi, Yuki, Shiomi, Hiroki, Morimoto, Takeshi, Tamaki, Yodo, Inoko, Moriaki, Yamamoto, Ko, Takeji, Yasuaki, Tada, Tomohisa, Nagao, Kazuya, Yamaji, Kyohei, Kaneda, Kazuhisa, Suwa, Satoru, Tamura, Toshihiro, Sakamoto, Hiroki, Inada, Tsukasa, Matsuda, Mitsuo, Sato, Yukihito, Furukawa, Yutaka, Ando, Kenji, Kadota, Kazushige, Nakagawa, Yoshihisa, and Kimura, Takeshi

Abstract

[Background] It remains controversial whether long‐term clinical impact of newly diagnosed atrial fibrillation (AF) in the acute phase of acute myocardial infarction (AMI) is different from that of prior AF diagnosed before the onset of AMI. [Methods and Results] The current study population from the CREDO‐Kyoto AMI (Coronary Revascularization Demonstrating Outcome Study in Kyoto Acute Myocardial Infarction) Registry Wave‐2 consisted of 6228 patients with AMI who underwent percutaneous coronary intervention. The baseline characteristics and long‐term clinical outcomes were compared according to AF status (newly diagnosed AF: N=489 [7.9%], prior AF: N=589 [9.5%], and no AF: N=5150 [82.7%]). Median follow‐up duration was 5.5 years. Patients with newly diagnosed AF and prior AF had similar baseline characteristics with higher risk profile than those with no AF including older age and more comorbidities. The cumulative 5‐year incidence of all‐cause death was higher in newly diagnosed AF and prior AF than no AF (38.8%, 40.7%, and 18.7%, P<0.001). The adjusted hazard ratios (HRs) for mortality of newly diagnosed AF and prior AF relative to no AF remained significant with similar magnitude (HR, 1.31; 95% CI, 1.12–1.54; P<0.001, and HR, 1.32; 95% CI, 1.14–1.52; P<0.001, respectively). The cumulative 5‐year incidence of stroke decreased in the order of newly diagnosed AF, prior AF and no AF (15.5%, 12.9%, and 6.3%, respectively, P<0.001). The higher adjusted HRs of both newly diagnosed AF and prior AF relative to no AF were significant for stroke, with a greater risk of newly diagnosed AF than that of prior AF (HR, 2.05; 95% CI, 1.56–2.69; P<0.001, and HR, 1.33; 95% CI, 1.00–1.78; P=0.048, respectively). The higher stroke risk of newly diagnosed AF compared with prior AF was largely driven by the greater risk within 30 days. The higher adjusted HRs of newly diagnosed AF and prior AF relative to no AF were significant for heart failure hospitalization (HR, 1.73; 95% CI, 1.35–

Published
2021

48. Effect of Heart Failure on Long‐Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery Disease

Author

50728037, 50860582, Yamamoto, Ko, Matsumura-Nakano, Yukiko, Shiomi, Hiroki, Natsuaki, Masahiro, Morimoto, Takeshi, Kadota, Kazushige, Tada, Tomohisa, Takeji, Yasuaki, Yoshikawa, Yusuke, Imada, Kazuaki, Domei, Takenori, Kaneda, Kazuhisa, Taniguchi, Ryoji, Ehara, Natsuhiko, Nawada, Ryuzo, Yamaji, Kyohei, Kato, Eri, Toyofuku, Mamoru, Kanemitsu, Naoki, Shinoda, Eiji, Suwa, Satoru, Iwakura, Atsushi, Tamura, Toshihiro, Soga, Yoshiharu, Inada, Tsukasa, Matsuda, Mitsuo, Koyama, Tadaaki, Aoyama, Takeshi, Sato, Yukihito, Furukawa, Yutaka, Ando, Kenji, Yamazaki, Fumio, Komiya, Tatsuhiko, Minatoya, Kenji, Nakagawa, Yoshihisa, Kimura, Takeshi, 50728037, 50860582, Yamamoto, Ko, Matsumura-Nakano, Yukiko, Shiomi, Hiroki, Natsuaki, Masahiro, Morimoto, Takeshi, Kadota, Kazushige, Tada, Tomohisa, Takeji, Yasuaki, Yoshikawa, Yusuke, Imada, Kazuaki, Domei, Takenori, Kaneda, Kazuhisa, Taniguchi, Ryoji, Ehara, Natsuhiko, Nawada, Ryuzo, Yamaji, Kyohei, Kato, Eri, Toyofuku, Mamoru, Kanemitsu, Naoki, Shinoda, Eiji, Suwa, Satoru, Iwakura, Atsushi, Tamura, Toshihiro, Soga, Yoshiharu, Inada, Tsukasa, Matsuda, Mitsuo, Koyama, Tadaaki, Aoyama, Takeshi, Sato, Yukihito, Furukawa, Yutaka, Ando, Kenji, Yamazaki, Fumio, Komiya, Tatsuhiko, Minatoya, Kenji, Nakagawa, Yoshihisa, and Kimura, Takeshi

Abstract

[Background] Heart failure might be an important determinant in choosing coronary revascularization modalities. There was no previous study evaluating the effect of heart failure on long‐term clinical outcomes after percutaneous coronary intervention (PCI) relative to coronary artery bypass grafting (CABG). [Methods and Results] Among 14 867 consecutive patients undergoing first coronary revascularization with PCI or isolated CABG between January 2011 and December 2013 in the CREDO‐Kyoto PCI/CABG registry Cohort‐3, we identified the current study population of 3380 patients with three‐vessel or left main coronary artery disease, and compared clinical outcomes between PCI and CABG stratified by the subgroup based on the status of heart failure. There were 827 patients with heart failure (PCI: N=511, and CABG: N=316), and 2553 patients without heart failure (PCI: N=1619, and CABG: N=934). In patients with heart failure, the PCI group compared with the CABG group more often had advanced age, severe frailty, acute and severe heart failure, and elevated inflammatory markers. During a median 5.9 years of follow‐up, there was a significant interaction between heart failure and the mortality risk of PCI relative to CABG (interaction P=0.009), with excess mortality risk of PCI relative to CABG in patients with heart failure (HR, 1.75; 95% CI, 1.28–2.42; P<0.001) and no excess mortality risk in patients without heart failure (HR, 1.04; 95% CI, 0.80–1.34; P=0.77). [Conclusions] There was a significant interaction between heart failure and the mortality risk of PCI relative to CABG with excess risk in patients with heart failure and neutral risk in patients without heart failure.

Published
2021

49. Different Kinetics of Activated Clotting Time Among Uninterrupted Oral Anticoagulants During Catheter Ablation Procedure.

Author

Kawaji, Tetsuma, Morimoto, Takeshi, Aizawa, Takanori, Hojo, Shun, Kushiyama, Akihiro, Yaku, Hidenori, Nakatsuma, Kenji, Kaneda, Kazuhisa, Kato, Masashi, Yokomatsu, Takafumi, Miki, Shinji, and Kimura, Takeshi

Subjects
ATRIAL fibrillation treatment, PYRIDINE, BODY weight, TIME, WARFARIN, MULTIPLE regression analysis, CATHETER ablation, ANTICOAGULANTS, BLOOD coagulation, BENZIMIDAZOLES, RIVAROXABAN, HEPARIN, LONGITUDINAL method
Abstract

Activated clotting time (ACT) kinetics under uninterrupted oral anticoagulants (OACs) has not been fully evaluated. The present study is sought to validate ACT kinetics including stability under uninterrupted use of OACs during an ablation procedure in daily clinical practice. We prospectively enrolled consecutive 554 patients with atrial fibrillation who underwent catheter ablation procedure under uninterrupted OACs. We evaluated ACT kinetics at an interval of 15 minutes during the procedure and periprocedural complications among 5 OACs (dabigatran [N = 46], rivaroxaban [N = 125], apixaban [N = 129], edoxaban [N = 184], and warfarin [N = 70]). Compared with the dabigatran group, time to achieve target ACT was significantly longer in the rivaroxaban and apixaban groups, but not in the edoxaban and warfarin groups (8.7 vs 11.7 minutes, P <.001; 13.3 minutes, P <.001; 8.8 minutes, P =.64; 10.3 minutes, P =.19, respectively). Heparin dose to achieve target ACT was comparable except for the warfarin group, whereas, compared with the dabigatran group, time in therapeutic range of ACT within the first hour was comparable in the rivaroxaban and apixaban group but significantly lower in the edoxaban and warfarin groups (73.7 % vs 63.0%, P =.06; 67.0 %, P =.16; 59.2 %, P =.001; 58.2%, P =.004, respectively). In multiple regression analysis, low body weight, rivaroxaban, apixaban, and morning session had significant associations with time and heparin dose to achieve target ACT, and there were positive associations of dabigatran and apixaban with time in therapeutic range of ACT within the first hour. The incidence of periprocedural complications did not significantly differ among the 5 groups. Under uninterrupted OAC use in daily clinical practice, dabigatran showed faster achievement of target ACT and higher stability of ACT than other OACs. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results